PH

PH is a biotechnology company focused on developing treatments for rare diseases, including a drug for Duchenne muscular dystrophy.

Why it’s in the news: It is in the news due to its clinical trial for a Duchenne muscular dystrophy drug being discussed in an opinion piece.

Latest on PH

• STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more
• 5 Best Electric Toothbrushes (2026): Philips, Oral-B, Quip, More
• Nyrius Phoenix Home True 4K60 (2026): A Solution for Cord Clutter
• My big, fat, technophobic cat
• Opinion: A cure for HIV would be a triumph. But it shouldn’t harm survivors
• Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?

Connections

17 entities linked to PH across the news graph.